Research progress of chondroitin sulfate proteoglycans in spinal cord injury
CSTR:
Author:
Affiliation:

Department of Orthopedics,The Second Hospital of Lanzhou University/Key Laboratory of Bone and Joint Diseases of Gansu Province

Clc Number:

R651.2

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Chondroitin sulfate proteoglycans(CSPGs) are components of the extracellular matrix of the central nervous system,and play key roles in the development,function maintenance,and pathological process of the central nervous system. After spinal cord injury,the expression of CSPGs at the injury site is significantly upregulated,which is mainly due to activated astrocytes at the lesion site. Upregulation of CSPGs can restrict axon regeneration,conduction,and re-myelination at the site of spinal cord injury,and can promote the inflammatory response in spinal cord injury,which impedes the recovery of nerve function after spinal cord injury. Therefore,inhibition of CSPGs may be an effective treatment to promote axonal regeneration and functional recovery after spinal cord injury. This study reviews the current status of research on CSPGs in spinal cord injury.

    Reference
    Related
    Cited by
Get Citation

Liu Yong, Shi Yongqiang, Mao Peng, Zhang Haihong. Research progress of chondroitin sulfate proteoglycans in spinal cord injury[J]. Journal of Chongqing Medical University,2024,49(3):231-236

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 20,2023
  • Revised:
  • Adopted:
  • Online: April 03,2024
  • Published:
Article QR Code